BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20015035)

  • 1. Medicinal chemistry of drugs used in diabetic cardiomyopathy.
    Adeghate E; Kalasz H; Veress G; Teke K
    Curr Med Chem; 2010; 17(6):517-51. PubMed ID: 20015035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyopathy and heart failure in diabetes.
    Tang WH; Young JB
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):1031-46. PubMed ID: 11727399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic cardiomyopathy.
    Karnik AA; Fields AV; Shannon RP
    Curr Hypertens Rep; 2007 Dec; 9(6):467-73. PubMed ID: 18367010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review.
    Adeghate E
    Mol Cell Biochem; 2004 Jun; 261(1-2):187-91. PubMed ID: 15362503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in the management of diabetic complications.
    Podar T; Tuomilehto J
    Drugs; 2002; 62(14):2007-12. PubMed ID: 12269846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
    Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T
    Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator activator receptors (PPAR), insulin resistance, and cardiomyopathy: friends or foes for the diabetic patient with heart failure?
    Nikolaidis LA; Levine TB
    Cardiol Rev; 2004; 12(3):158-70. PubMed ID: 15078585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic cardiomyopathy].
    Terashima M; Goto Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():347-53. PubMed ID: 12430252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug treatment of heart failure--what's new after the era of angiotensin converting enzyme inhibitors].
    Gierlotka M; Adamowicz-Czoch E
    Pol Arch Med Wewn; 1999 Mar; 101(3):259-67. PubMed ID: 10697405
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant therapy in diabetic complications: what is new?
    Da Ros R; Assaloni R; Ceriello A
    Curr Vasc Pharmacol; 2004 Oct; 2(4):335-41. PubMed ID: 15320813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of obesity hypertension and diabetes syndrome.
    Zanella MT; Kohlmann O; Ribeiro AB
    Hypertension; 2001 Sep; 38(3 Pt 2):705-8. PubMed ID: 11566961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2009 Sep; 150(39):1813-23. PubMed ID: 19758961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications.
    Tsujino T; Kawasaki D; Masuyama T
    Am J Cardiovasc Drugs; 2006; 6(4):219-30. PubMed ID: 16913823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.
    Weck M
    Clin Res Cardiol; 2007 Oct; 96(10):707-18. PubMed ID: 17593318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.
    Teupe C; Rosak C
    Diabetes Res Clin Pract; 2012 Aug; 97(2):185-94. PubMed ID: 22502812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.